Cassady Schiller Wealth Management, LLC Blueprint Medicines Corp Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 8 shares of BPMC stock, worth $832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8Holding current value
$832% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
362Shares Held
61.8MCall Options Held
2.24MPut Options Held
1.15M-
Vanguard Group Inc Valley Forge, PA6.77MShares$705 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$691 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$560 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$412 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$288 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.21B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...